Elevation Oncology Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 4, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	2016 - 2020
Market Capitalization	1,215	622	212	37	145	159	Upgrade
Market Cap Growth	198.45%	193.56%	471.11%	-74.39%	-8.64%	104.05%	Upgrade
Enterprise Value	1,183	642	215	53	143	136	Upgrade
Last Close Price	0.65	0.34	0.13	0.03	0.14	0.25	Upgrade
PE Ratio	18.62	22.56	-	-	-	-	Upgrade
Forward PE	7.29	-	-	-	-	-	Upgrade
PS Ratio	3.99	2.90	1.56	0.24	5.77	-	Upgrade
PB Ratio	7.97	6.43	6.82	1.07	1.42	3.30	Upgrade
P/TBV Ratio	7.97	6.43	6.82	1.07	1.42	3.30	Upgrade
P/OCF Ratio	10.39	17.16	-	1.50	-	-	Upgrade
EV/Sales Ratio	3.89	3.00	1.58	0.35	5.68	-	Upgrade
EV/EBITDA Ratio	10.92	21.40	-	8.18	-	-	Upgrade
EV/EBIT Ratio	16.89	29.27	-	-	-	-	Upgrade
Debt / Equity Ratio	0.17	0.32	1.02	0.70	0.27	0.01	Upgrade
Debt / EBITDA Ratio	0.24	0.68	-	1.21	-	-	Upgrade
Asset Turnover	1.54	1.38	1.26	1.13	0.21	-	Upgrade
Inventory Turnover	9.16	8.87	9.63	8.72	2.55	-	Upgrade
Quick Ratio	0.84	0.44	0.73	0.84	0.82	2.69	Upgrade
Current Ratio	1.18	0.83	1.17	1.33	1.49	2.70	Upgrade
Return on Equity (ROE)	68.50%	43.12%	-133.87%	-128.51%	-29.70%	-16.01%	Upgrade
Return on Assets (ROA)	22.09%	8.83%	-27.21%	-32.26%	-11.17%	-6.90%	Upgrade
Return on Capital (ROIC)	33.32%	14.38%	-48.00%	-46.80%	-15.37%	-10.29%	Upgrade
Return on Capital Employed (ROCE)	39.30%	17.10%	-	-	-	-	Upgrade
Earnings Yield	5.57%	4.43%	-20.83%	-237.04%	-15.38%	-4.21%	Upgrade
FCF Yield	2.08%	-5.28%	-18.97%	-38.91%	-40.55%	-13.28%	Upgrade
Buyback Yield / Dilution	-27.34%	-37.43%	-24.86%	-34.00%	-45.86%	-638.60%	Upgrade

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.